Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2015

Jan 21, 2015

30339_dirs_2015-01-21_45ffb661-64ce-4980-9abe-433125e141eb.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2015-01-12

Reporting Person: MOREL DONALD E JR (Chair of the Board & CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-01-12 Common Stock G 9300.0000 $0.0000 Disposed 782595.6717 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 2705.6000 Indirect
Common Stock 24599.6700 Indirect